gratisspinscoinmaster| *ST Target Pharmaceutical: The subsidiary plans to implement production capacity improvement and technological transformation projects with 100 million yuan

*ST Eye Drug AnnouncementgratisspinscoinmasterHuangshan Tianmu, a wholly-owned subsidiary of the company, plans to invest about 10gratisspinscoinmaster, 0 million yuangratisspinscoinmaster, build a new production workshop in the existing factory area, optimize and transform the original production line, increase production capacity, build an intelligent, digital and information-based factory, and become a modern Chinese medicine production enterprise with market competitiveness.